How to Help Your Patients Find Megestrol in Stock: A Provider's Guide

For providers in oncology, infectious disease, palliative care, and primary care, the Megestrol acetate tablet shortage has added a frustrating new layer to already complex patient management. When patients call your office unable to fill their prescription, a clear workflow — rather than ad hoc troubleshooting — helps your team respond efficiently. This guide provides a practical, step-by-step approach.

Step 1: Proactively Identify At-Risk Patients

Don't wait for patients to call in a panic with three days of medication left. Pull a list of patients currently on Megestrol acetate tablets (20 mg or 40 mg) and contact them proactively. Patients on high doses (400-800 mg/day) for cachexia or cancer have the most to lose from supply interruptions — and the highest risk of HPA axis suppression if they stop abruptly.

Recommended proactive actions:

Send a patient portal message or brief phone call to all active Megestrol patients explaining the shortage

Ask patients to check their remaining supply and report back if they have fewer than 2 weeks on hand

Pre-authorize refills for patients likely to face supply gaps

Step 2: Direct Patients to Independent and Specialty Pharmacies

Independent pharmacies often source from different wholesalers than major chains and may have stock when CVS, Walgreens, and Rite Aid don't. Specialty pharmacies that serve oncology or HIV patients are particularly worth contacting — they often maintain larger inventories of niche drugs like Megestrol.

Your office staff can maintain a short list of local independent pharmacies and specialty pharmacies that serve your patient population. Establish these relationships before a crisis hits.

Step 3: Use medfinder for Providers

Recommend medfinder for Providers to patients who are actively searching for their medication. medfinder contacts pharmacies near the patient's location to check which ones can fill their Megestrol prescription. Results are texted directly to the patient — no endless phone calls for the patient or your staff.

Step 4: Consider Compounding Pharmacy Options

Licensed compounding pharmacies can prepare megestrol acetate formulations when commercial products are unavailable. This requires a prescription specifically written for the compounded product. For patients requiring the oral suspension (the primary AIDS-related cachexia formulation), compounding pharmacies can often prepare appropriate concentrations with short turnaround times. Verify the pharmacy is licensed by the state board and holds appropriate FDA registration (503A or 503B).

Step 5: Consider Alternative Formulations With a New Rx

If tablets are unavailable but oral suspension is in stock, the switch is clinically feasible for many patients — but the dose must be explicitly recalculated. The standard 40 mg/mL suspension at 20 mL/day = 800 mg/day. The Megace ES 125 mg/mL at 5 mL/day = 625 mg/day. Never assume a patient or pharmacist will perform the conversion correctly without explicit prescribing instructions. Write the new prescription with the formulation, concentration, volume, and total daily dose explicitly stated.

Step 6: Initiate Alternatives When Supply Cannot Be Found

When all supply options are exhausted, switch to an appropriate alternative based on indication:

AIDS-related cachexia: Dronabinol (Marinol) or mirtazapine (off-label)

Cancer-related cachexia: Dexamethasone (short-term), mirtazapine, or olanzapine

Advanced endometrial cancer: High-dose medroxyprogesterone acetate

Breast cancer: Aromatase inhibitors or medroxyprogesterone acetate

Step 7: Manage Transitions Carefully — Taper When Possible

For patients who have been on Megestrol for more than 4-6 weeks at doses of 400 mg/day or higher, do not abruptly discontinue without a taper plan. The glucocorticoid activity of megestrol acetate at high doses produces HPA axis suppression comparable to moderate-dose prednisone. A step-down taper over 2-4 weeks — or bridge coverage with a short course of prednisone or dexamethasone during the transition — reduces the risk of adrenal crisis.

Patient Communication Template

Here is a sample patient portal message your team can adapt:

"We want you to know that Megestrol acetate tablets are currently in a national shortage. If you take Megestrol, please check how many doses you have left and contact us if you have less than a 2-week supply. Do not stop taking your medication without calling us first. We are working to identify alternative sources and can provide guidance if your pharmacy is unable to fill your prescription."

For a comprehensive clinical overview of the shortage, see: Megestrol Shortage: What Providers and Prescribers Need to Know in 2026.